<level type="section">
  <num>48-844.01</num>
  <heading>Short title.</heading>
  <text>This chapter may be cited as the "SafeRX Evaluation Act of 2008".</text>
  <level>
    <type>annotations</type>
    <level>
      <heading>CREDIT(S)</heading>
      <text>(Mar. 26, 2008, D.C. Law 17-131, ยง 501, 55 DCR 1659.)</text>
    </level>
    <level>
      <heading>HISTORICAL AND STATUTORY NOTES</heading>
      <level>
        <heading>Legislative History of Laws</heading>
        <text>Law 17-131, the "SafeRx Amendment Act of 2008", was introduced in Council and assigned Bill No. 17-364 which was referred to the Committee on Health. The Bill was adopted on first and second readings on December 11, 2007, and January 8, 2008, respectively. Signed by the Mayor on February 1, 2008, it was assigned Act No. 17-282 and transmitted to both Houses of Congress for its review. D.C. Law 17-131 became effective on March 26, 2008.</text>
      </level>
      <level>
        <heading>Delegation of Authority</heading>
        <text>Delegation of Authority pursuant to D.C. Law 17-131, the SafeRX Amendment Act of 2008, see Mayor's Order 2008-94, July 3, 2008 (55 DCR 9375).</text>
      </level>
    </level>
  </level>
</level>
